Member Exclusive News

The week in industry: US FDA awards 12 grants to fund rare disease treatment programs

This week: US$3 million payment for nomination of new GPCR target, orphan drug designation granted for soft tissue sarcoma treatment and erythropoietic protoporphyria drug approved for marketing in the US.

Go to the profile of RxNet
Oct 10, 2019

Please sign in or register for FREE

No comments yet.